Ophthalmology Market Analysis and Reports | Switzerland Conference Series

Market Analysis - Ophthalmology 2017

Why Zurich?

Zurich has a unique position in Switzerland. It is the country's largest city and home to an internationally reputed financial centre as well as being the focus of an economic region which acts as the motor of Switzerland, and along with Geneva is the most important gateway to the country.

The wide variety of cultural activities and educational institutions define Zurich's character as a diverse, open city with a passion for life. Zurich is the capital of the canton of the same name and the centre of a number of regions which together have some 1.9 million inhabitants. It is famous for its lakeside location and green, densely wooded chain of hills which run through the city from north to south.

Zurich's place on the world stage does not come down to its size but to its strong international networks. The high standards of living, working and accommodation are regularly confirmed in surveys of the local residents, and Zurich consistently finds itself at the top of international rankings of cities in terms of quality of life.

Zürich is the largest city in Switzerland with a population of over 380,500, an increase of 19,500 since year 2000.  1.1 million people live in Zürich agglomeration, while there are 1.9 million in the metropolitan area. By 2008, 31% of the city's population was made up of non-Swiss from a total of 166 different countries, all of whom help to make up Zürich's multi-cultural character. 10% of all foreigners who move to Switzerland come to the City of Zürich, emphasizing its central role as an economic hub. Germans make up the largest group with 27,870 living in the city, followed by Italians 13,598 and Serbia and Montenegro with 10,245.

One out of every nine jobs in Switzerland is in the City of Zürich, while 82 of 208 banking institutions in Switzerland have their headquarters here. The total assets of these banks correspond to 85.1% of the total value of all assets held in Switzerland. One out of every five jobs in the creative economy can also be found in Zürich, and these generate CHF 9.2 billion – 15% of Switzerland's entire revenue.

Some 110 hotel companies with 11.500 beds at their disposal provide 2.5 million overnight stays every year, while Zürich airport looks after around 20 million passengers.

Why to attend?

With members from around the world focused on learning about clinical ophthalmology, this is the single best opportunity to reach the largest assemblage of participants from the ophthalmology community. Conduct workshops, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 3 days event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in field of ophthalmology are hallmarks of this conference.

Target Audience:

  • Neuropharmacology Students, Scientists
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Medical Colleges
  • Neuropharmacology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

Due to high incidence of eye disorders especially amongst geriatrics and increased number of cataract population, the global ophthalmic drugs and device market is set to grow exponentially in the coming years.  The increased number of ophthalmic incidence leads to the production of new ophthalmic devices to treat the sickness and patients are also ready to get operated via ophthalmic surgeries to maintain the health of their eye and vision.

The significant growth of the global ophthalmic drugs and devices market in the past few years is because of the high incidence of eye diseases such as diabetic retinopathy, age related macular degeneration, glaucoma, cataract, vision correction surgery, eye cancer (retinoblastoma), corneal transplantation, retinopathy of prematurity etc.

The global ophthalmology market is very big and the market report is classified into various categories such as, ophthalmology drugs, devices, diagnostic tools, surgical tools and then further classification is done based on the geography, devices, diseases, surgical tools etc.

 

The European Ophthalmology Drugs and Devices Market are valued as a $12.47 billion market in 2016 and are expected to reach a value of $16.63 billion by 2021 at a CAGR of 5.92%.

According to the report the Ophthalmology Diagnostics and Surgical Devices Market (Corneal Topographers, Optical Coherence Tomography, Echography, Specular Microscopes, Cataract, Refractive, Glaucoma and Vitreoretinal Surgery Devices)- Global Industry Study, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Ophthalmology Devices market was valued at USD26,012.6million in 2012 and projected to touch a market worth USD40,381.6 million in 2019 at a CAGR of 6.6 % from 2013 to 2019.

The European cataract surgery tools and devices market is classified according to the type of products (phacoemulsification devices, intraocular lenses and ophthalmic viscoelastic devices). The highest share of the market is occupied by intraocular lenses in 2014 around 69.9% followed by phacoemulsification devices. The cataract surgery market of European region is expected to grow at a CAGR of 5.9% by 2019.

The major share of cataract surgery devices market is occupied by Germany, followed by France and it is because of high incidence of eye disorders in these regions of Europe. Moreover, government support for cataract surgery also leads to the growth of cataract surgery devices market in Europe.